1. Home
  2. JRVR vs TKNO Comparison

JRVR vs TKNO Comparison

Compare JRVR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo James River Group Holdings Ltd.

JRVR

James River Group Holdings Ltd.

HOLD

Current Price

$6.25

Market Cap

265.7M

Sector

Finance

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$3.88

Market Cap

236.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JRVR
TKNO
Founded
2002
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.7M
236.6M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
JRVR
TKNO
Price
$6.25
$3.88
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$6.25
N/A
AVG Volume (30 Days)
281.8K
128.5K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
0.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$646,580,000.00
$39,801,000.00
Revenue This Year
N/A
$8.79
Revenue Next Year
$0.17
$10.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.50
52 Week Low
$3.00
$3.85
52 Week High
$6.89
$10.37

Technical Indicators

Market Signals
Indicator
JRVR
TKNO
Relative Strength Index (RSI) 52.02 30.91
Support Level $6.26 $3.85
Resistance Level $6.48 $4.86
Average True Range (ATR) 0.23 0.29
MACD -0.05 -0.07
Stochastic Oscillator 35.00 14.17

Price Performance

Historical Comparison
JRVR
TKNO

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: